semaglutide rheumatoid arthritis ACR 2025: GLP-1 Drugs Reduce Rheumatoid Arthritis Flares GLP-1 Receptor Agonists May Improve

Anderson, FASAE, CAE, IOM President & Chief Executive Officer Date: June 4, 2026 Beginning July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will launch the Medicare GLP-1 Bridge Program, a temporary demonstration designed to provide

GLP-1 SM is a synthetic peptide reference compound modeled on a glucagon-like peptide-1 (GLP-1) receptor agonist sequence, extensively referenced in metabolic

Polyendocrine metabolic ovarian syndrome (PMOS) reframes PCOS as a whole-body endocrine-metabolic disorder, with better diagnosis and care

Activated AMPK promotes ATP production and storage within cells, primarily by inhibiting ATP-consuming anabolic processes (such as protein, lipid, and ribosomal synthesis) and initiating ATP-producing catabolic pathways (such as fatty acid oxidation and glycolysis) to maintain energy homeostasis

Learn how GLP-1/GIP weight loss may affect low T, estrogen, belly fat, and TRT

Wegovy sex side effects explained: discover how this weight loss medication may indirectly affect sexual function, practical management strategies, and when to consult your GP about changes in sexual health during treatment.